1. Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II‐IIIA non‐small cell lung cancer: Propensity score‐matched and instrumental variable analyses
    Hirokazu Urushiyama et al, 2018, Cancer Medicine CrossRef
  2. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
    Norihito Okumura et al, 2021, BMC Cancer CrossRef
  3. The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross‑complementation group 1 and class III β‑tubulin, and the therapeutic effect of S‑1 or carboplatin plus paclitaxel in non‑small‑cell lung cancer
    Katsuhiro Okuda et al, 2018, Molecular and Clinical Oncology CrossRef
  4. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer
    Tatsuro Okamoto et al, 2018, Lung Cancer CrossRef
  5. Efficacy of S-1 in non-small cell lung cancer
    Masaaki Kawahara, 2014, Expert Opinion on Pharmacotherapy CrossRef
  6. S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage�II/IIIA non‑small‑cell lung cancer
    Katsuhiro Okuda et al, 2017, Molecular and Clinical Oncology CrossRef
  7. Prognostic Impact of the ABCC11/MRP8 Polymorphism in Adjuvant Oral Chemotherapy with S-1 for Non-Small Cell Lung Cancer
    Tomoshi Tsuchiya et al, 2016, Chemotherapy CrossRef
  8. A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S‐1 in patients with stage II‐IIIA non‐small cell lung cancer
    Mitsuhiro Tsuboi et al, 2018, The Journal of Medical Investigation CrossRef
  9. Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701
    Junichi Soh et al, 2016, Japanese Journal of Clinical Oncology CrossRef
  10. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer
    Keiji Yamanashi et al, 2017, Asian Cardiovascular and Thoracic Annals CrossRef
  11. Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial
    Yoshinobu Hata et al, 2017, BMC Cancer CrossRef